Publications by authors named "Mathieu Pankert"

Claim this Profile
[
[Outpatient coronary angiography and angioplastie/ why, how and for wich patients?].
Marine Quillot, Raphaël Lasserre, Karim Moussa, Mathieu Pankert, Candice Venturelli

Ann Cardiol Angeiol (Paris)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of the ULYSS trial: A randomized multicenter evaluation of the efficacy of early Impella CP implantation in acute coronary syndrome complicated by cardiogenic shock.
Clement Delmas, Marc Laine, Guillaume Schurtz, Francois Roubille, Pierre Coste, Mathieu Pankert

Am Heart J· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Extensive cardiac thombosis in a patient with disseminated intravascular coagulation].
Falah Aboukhoudir, Jason Veyrier, Alexandra Dernys, Karim Moussa, Mathieu Pankert

Ann Cardiol Angeiol (Paris)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ruptured sinus of Valsalva aneurysm presenting as an idiopathic pericardial effusion].
F Aboukhoudir, N Jaussaud, Sofiéne Rekik, Mathieu Pankert

Ann Cardiol Angeiol (Paris)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Thrombus on a Journey: A Massive Thrombus in Transit With Cerebral, Coronary, and Pulmonary Embolization.
Falah Aboukhoudir, Aymen Najjar, Karim Moussa, Gilbert Habib, Mathieu Pankert

Can J Cardiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TicagRelor Or Clopidogrel in severe or terminal chronic kidney patients Undergoing PERcutaneous coronary intervention for acute coronary syndrome: The TROUPER trial.
Marc Laine, Gilles Lemesle, Stéphane Burtey, Guillaume Cayla, Grégoire Range, Mathieu Pankert

Am Heart J· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment: The EARLY Randomized Trial.
Gilles Lemesle, Marc Laine, Mathieu Pankert, Ziad Boueri, Pascal Motreff

JACC Cardiovasc Interv· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Femoral Versus Nonfemoral Peripheral Access for Transcatheter Aortic Valve Replacement.
Sylvain Beurtheret, Nicole Karam, Noemie Resseguier, Remi Houel, Thomas Modine, Mathieu Pankert

J Am Coll Cardiol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial.
Gilles Lemesle, Marc Laine, Mathieu Pankert, Etienne Puymirat, Thomas Cuisset

Clin Cardiol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Great expectations.
Gilles Lemesle, Marc Laine, Mathieu Pankert, Etienne Puymirat, Laurent Bonello

Lancet· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Radiation Exposure of the Imaging Specialist During Structural Heart Interventions With Echocardiographic Guidance.
Erwan Salaun, Stephanie Carles, Emeline Bigand, Mathieu Pankert, Philippe Aldebert

JACC Cardiovasc Interv· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.
Guillaume Bonnet, Erwan Salaun, Mathieu Pankert, Thomas Cuisset, Jean-Louis Bonnet

Arch Cardiovasc Dis· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic heart failure in heart transplant recipients: Presenting features and outcome.
Pierre Ambrosi, Bernard Kreitmann, Alberto Riberi, Marc Lambert, Mathieu Pankert

Arch Cardiovasc Dis· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How should I treat refractory cardiogenic shock in a patient with chronic biventricular heart failure and mitral regurgitation with difficult valve characteristics?
Erwan Salaun, Mathieu Pankert, Gilbert Habib, Jean-Louis Bonnet, Alec Vahanian

EuroIntervention· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new approach: Left atrial appendage occlusion, as an alternative to anticoagulant, to treat patient who suffered of atrial fibrillation, acute coronary syndrome and clopidogrel resistance.
Mathieu Pankert, Erwan Salaun, Thomas Cuisset, Jean-Louis Bonnet

Int J Cardiol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic kidney disease has a significant impact on platelet inhibition of new P2Y12 inhibitors.
Pierre Deharo, Mathieu Pankert, Jacques Quilici, Guillaume Bonnet, Clemence Bassez

Int J Cardiol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of switching 'low responders' to prasugrel to ticagrelor after acute coronary syndrome.
Clémence Bassez, Pierre Deharo, Mathieu Pankert, Guillaume Bonnet, Jacques Quilici

Int J Cardiol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index has no impact on platelet inhibition induced by ticagrelor after acute coronary syndrome, conversely to prasugrel.
Pierre Deharo, Mathieu Pankert, Guillaume Bonnet, Jacques Quilici, Clemence Bassez

Int J Cardiol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient right internal thoracic arterial graft kink related to respiratory movements: documentation of its existence, relevance and proposed management.
Mathieu Pankert, Philippe L L'Allier, Jean-Claude Tardif

Catheter Cardiovasc Interv· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual cause of hypoxemia in myocardial infarction: interventional management.
Mathieu Pankert, Thomas Cuisset, Philippe Aldebert, Guilhem Cavaille, Jacques Quilici

Int J Cardiol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-dose aspirin-clopidogrel combination enhances compliance to aspirin after acute coronary syndrome.
Pierre Deharo, Jacques Quilici, Guillaume Bonnet, Mathieu Pankert, Valentine Verdier

Int J Cardiol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of obesity and the metabolic syndrome on response to clopidogrel or prasugrel and bleeding risk in patients treated after coronary stenting.
Mathieu Pankert, Jacques Quilici, Anderson Diendonné Loundou, Valentine Verdier, Marc Lambert

Am J Cardiol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prasugrel versus ticagrelor in acute coronary syndrome: a randomized comparison.
Pierre Deharo, Clemence Bassez, Guillaume Bonnet, Mathieu Pankert, Jacques Quilici

Int J Cardiol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of switching 'hyper responders' from Prasugrel to Clopidogrel after acute coronary syndrome: the POBA (Predictor of Bleeding with Antiplatelet drugs) SWITCH study.
Pierre Deharo, Coline Pons, Mathieu Pankert, Guillaume Bonnet, Jacques Quilici

Int J Cardiol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications of very low on-treatment platelet reactivity in patients treated with thienopyridine: the POBA study (predictor of bleedings with antiplatelet drugs).
Thomas Cuisset, Charlotte Grosdidier, Anderson Diendonné Loundou, Jacques Quilici, Marie Loosveld, Mathieu Pankert

JACC Cardiovasc Interv· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis